48 results
424B5
BEAM
Beam Therapeutics Inc
10 May 23
Prospectus supplement for primary offering
5:10pm
, business, and operational uncertainty, including as a result of geopolitical events or other global or regional events such as the COVID-19 pandemic.
All
8-K
EX-99.1
6ndff68we
7 Nov 22
Beam Therapeutics Announces Portfolio Progress and Reports Third Quarter 2022 Financial Results
7:00am
8-K
EX-99.1
s870v 2y7uk7w
9 Aug 22
Beam Therapeutics Announces Pipeline and Business Highlights and Reports Second Quarter 2022 Financial Results
7:00am
8-K
drqn2x99
1 Aug 22
Beam Therapeutics Announces FDA Clinical Hold on BEAM-201 IND Application
6:50am
8-K
EX-99.1
fkrjot95yl9zy1uon5q
1 Aug 22
Beam Therapeutics Announces FDA Clinical Hold on BEAM-201 IND Application
6:50am
8-K
EX-99.1
fi2mexj
9 May 22
Beam Therapeutics Announces Pipeline and Business Highlights and Reports First Quarter 2022 Financial Results
7:01am
8-K
EX-99.1
8m7j03 06
28 Feb 22
Beam Therapeutics Reports Pipeline and Business Highlights, Planned 2022 Milestones and Fourth Quarter and Full Year 2021 Financial Results
7:00am
8-K
EX-99.1
x4o2e gkd
10 Jan 22
Results of Operations and Financial Condition
6:45am
8-K
wtkpg318n
10 Jan 22
Results of Operations and Financial Condition
6:45am
8-K
EX-99.2
1sbha cj7q
10 Jan 22
Results of Operations and Financial Condition
6:45am